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Abstract 
For patients with diabetes in acute care settings, researchers report that it is challenging for the 
healthcare team to coordinate capillary blood glucose (CBG) monitoring and insulin 
administration with mealtimes. If insulin dosage is calculated from CBG values that are not 
updated, patients may experience dosing errors and uncontrolled CBG. Uncontrolled CBG 
increases patients’ risk of complications. To improve diabetes management, some hospitals have 
implemented policies aimed at improving the coordination of CBG monitoring, insulin 
administration, and mealtimes. In this study, the researcher studied the effectiveness of including 
an educational card on patient meal trays on the timing of CBG monitoring, insulin 
administration, and meal tray delivery. The effect on glycemic control was also examined. The 
educational card was placed on patient meal trays and prompted the patient to contact the nurse 
to receive meal-time insulin before the consumption of the meal. Data were collected on 60 
patients (control group n = 30, test group n = 30) at a 433-bed level-1 trauma center in central 
Illinois. The educational card did not significantly decrease the timing between CBG monitoring, 
insulin administration, and meal tray delivery, but the implications from this study can be 
replicated or modified to meet the needs of other hospitals interested in improving diabetes 
management.  
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Improving Timing of Capillary Blood Glucose Monitoring and 
Insulin Administration through Patient Education 
In the acute care setting, 38-46% of patients with diabetes experience hyperglycemia 
(Mendez & Umpierrez, 2014). Per the guidelines of the American Diabetes Association (ADA) 
(2019), capillary blood glucose (CBG) should be maintained between 140-180 mg/dL in the 
inpatient setting, and can be maintained between 110-140 mg/dL for selected, non-critical 
patients. Any CBG above 180 mg/dL is considered hyperglycemia while anything below 70 
mg/dL is considered hypoglycemia. Diabetes management in hospitalized patients is inadequate 
and does not meet standards. Uncontrolled CBG increases the risk of complications and results 
in longer hospital stays, increasing the financial burden for the patient and hospital (Majumdar et 
al., 2013).  
Glycemic management in the hospital setting is challenging, but can be improved through 
modifiable factors. CBG monitoring, insulin administration, and meal consumption in the 
inpatient setting are not done within the appropriate timeframe (Freeland, Penprase, & Anthony, 
2011; Lampe, Penoyer, Hadesty, Bean, & Chamberlain, 2014; Mendez & Umpierrez, 2014). 
Inadequate coordination between CBG monitoring, insulin administration, and meal 
consumption results in uncontrolled CBG. According to current recommendations by the ADA 
(2019), CBG monitoring should occur closely before the administration of insulin (a time 
interval was not specified), and rapid-acting insulin, Novolog or Humalog, should be 
administered 15 minutes before or directly after meal consumption. Few researchers identified 
barriers at adhering to guidelines, but insufficient communication and coordination between the 
healthcare team and low inadequate staffing are key factors (Kaisen, Parkosewich, & Bonito, 
2018).  
CBG MONITORING AND INSULIN ADMINISTRATION 4 
 The purpose of this study was to examine the effect of an educational card on the time 
intervals between CBG monitoring, insulin administration, and meal tray delivery. Time of meal 
tray delivery served as a proxy for timing of meal consumption, as the hospital requested the 
researcher have no direct patient contact. The aim of the study was to address the following 
questions: 
1. Does the placement of an educational card on patient meal trays shorten the time 
intervals between: 
a. CBG and meal tray delivery, 
b. the administration of insulin and meal tray delivery, 
c. and CBG and the administration of insulin?  
2. Is the incidence of hypoglycemia, defined as any CBG <70mg/dL, decreased in the 
interval after meal tray delivery and before the next meal after the implementation of 
the educational card? 
3. Is the percentage of patients in blood glucose range, measured by a target range of 70-
180 mg/dL, increased after the implementation of the educational card? 
Literature Review 
Research published from 2010 to 2019 is limited on interventions to improve glycemic 
management in the inpatient setting, but some researchers were successful at lowering the 
incidence of uncontrolled CBG and improving the timing between CBG monitoring, insulin 
administration, and meal consumption (Engle, Ferguson, & Fields, 2016; Yamamoto, 
Malatestinic, Lehman, & Juneja, 2010). For example, instead of dietary staff, nurses delivered 
meal trays to patients receiving insulin, which improved CBG management and timing. This 
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additional responsibility strained the nursing staff, interrupted work flow, and was not feasible 
during times of high census (Engle et al., 2016).  
Other researchers developed markings and identification for patient meal trays, which 
improved the coordination of CBG monitoring and insulin administration. These interventions 
are low-cost, but require the coordination between nursing and dietary staff (Yamamoto et al., 
2010). Coordination of CBG monitoring and insulin administration improved with increased 
communication between nursing and dietary staff. Nurses could plan insulin administration 
accordingly as they were informed of meal tray delivery (Engle et al., 2016; Yamamoto et al., 
2010). Improved communication with certified nursing assistants (CNAs) also facilitated CBG 
monitoring closer to insulin administration (Kaisen et al., 2018).  
According to researchers and the ADA, inpatient diabetes education is essential at 
improving diabetes management (Powers et al., 2015). Inpatient glycemic management improves 
when patients are able to identify the need to have insulin before meal consumption. Inpatient 
diabetes education also promotes replication and adherence to teaching upon discharge. Patient 
education increases autonomy, promotes healthy habits, and provides a greater sense of health 
awareness (Cobaugh et al., 2013; Engle et al., 2016; Kaisen et al., 2018).  
Research is limited on the effectiveness of interventions to promote glycemic 
management in the inpatient setting. Inpatient glycemic management can improve through the 
coordination of CBG monitoring, insulin administration, and meal consumption. Few researchers 
have identified solutions at improving timing; therefore, further research is needed. It is possible 
that facilities have made practice changes to improve the coordination of CBG and insulin 
administration, but have not published, evaluated, or disseminated that change. Appendix A 
provides greater detail on the current published research within this literature review.    
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Methods 
Study Design 
A quasi-experimental, non-equivalent control group before-after design with 
retrospective chart reviews was used in the study. Data was collected from the control group 
without the educational card, and then data was collected from the test group with the 
educational card. The control and test groups consisted of different participants and data 
collection occurred on separate days.  
Participants and Sampling Procedures 
The total sample size was 60 with 30 participants in the control group and 30 participants 
in the test group. Inclusion criteria included English-speaking patients prescribed rapid-acting 
meal-time insulin admitted to non-critical, acute care units. Over the period of two months, the 
researcher worked with an advanced practice register nurse (APRN) with a specialty in diabetes 
to select participants for the study. Each day, the APRN examined unit census and created a list 
of patients on rapid-acting meal-time insulin in non-critical, acute care units. Exclusion criteria 
included patients not prescribed rapid-acting meal-time insulin, not assigned to non-critical, 
acute care units, or non-English speaking.     
The study was conducted at 433-bed level-1 trauma center in central Illinois. Institutional 
Review Board (IRB) approval was granted from Illinois Wesleyan University. The hospital IRB 
approved the study as a quality improvement (QI) project with no direct participant contact. 
Participant consent was not obtained as there was no direct participant contact and minimal risk 
to participants. The educational card was created on the basis of accepted and published 
guidelines on diabetes care. The waiver of consent did not adversely affect the rights and welfare 
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of the subjects and all data collected were de-identified and stored in a password protected and 
encrypted computer to minimize risk of exposure of health information.    
Patient Education Card  
The patient education card (Appendix B) was created by the researcher in collaboration 
with the APRN diabetes specialist. The goal of the education card was to catch the attention of 
the participant and prompt the participant to call the nurse to receive insulin before proceeding to 
meal consumption. Nurses, CNAs, dietary staff, and unit managers were notified of the 
intervention via email. The card used plain and simple language. The researcher used Microsoft 
Office PowerPoint® and images in the Creative Commons labeled for reuse to create the card.    
Data Collection 
Data collection occurred in collaboration with the APRN and dietary staff. At the 
beginning of the day, the APRN informed dietary staff of the room numbers associated with 
study participants. Dietary staff informed the APRN when the participant ordered and when the 
meal tray left the kitchen. The researcher or the APRN went to the unit and recorded the time of 
meal tray delivery to the nurse’s station and subsequently to the patient room. Paired data were 
not available for every patient because of physical availability limitations of the researcher and 
APRN. For example, meal trays were often delivered at the same time which made it impossible 
to record the time the tray reached the nurse’s station for multiple units. Data collection occurred 
first with the control group and then proceeded with the test group. For the test group, the 
researcher or APRN placed the educational card directly on patient meal trays prior to delivery 
into the patient room. 
The researcher and APRN used retrospective chart reviews to collect demographic 
information, clinical characteristics, CBG values, and the timing of CBG monitoring and insulin 
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administration. CBG values before and after the observed meal were recorded. Paired data were 
not available for every participant due to discharges and procedures; therefore, some results from 
the control and test groups have sample size less than 30. Insulin timing was only recorded if 
insulin was administered. Some patients refused insulin or insulin was not given due to clinical 
indications not met (e.g., hypoglycemia). Participant unit, age, gender, hemoglobin A1C, 
diabetes type, primary diagnosis, length of stay (LOS), meal observed and diet order were 
recorded. Data collection occurred from November 2019 through January 2020.     
Data Analysis 
Data were analyzed using IBM SPSS Statistics version 26. Descriptive statistics were 
used to analyze and report data using percentages, means, and standard deviations. Demographic 
data from the control and test groups were compared through descriptive analysis, chi-squared 
tests, and independent samples t-tests. Mean time intervals and CBG values from the control and 
test groups were compared through chi-squared tests and independent samples t-tests. Percent of 
the control and test groups in range was compared using chi-squared tests. Subgroups were 
created within the data from hemoglobin A1C, diet ordered, and meal observed and analyzed 
using independent samples t-tests.  
Results 
Demographic Characteristics  
The demographic characteristics of the control and test groups did not differ significantly 
(Appendix C), indicating both groups had similar participants. The average age in the control 
group was 67.03 (SD = 13.86) and 65.07 (SD = 12.08) in the test group (t(58) = 0.59, p = 0.56). 
Gender did not differ significantly between groups (X2(32, N = 60) = 31.82, p = 0.48). In the 
control group, 43% of participants were male and 57% of participants were female. In the test 
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group, 37% of participants were male and 63% of participants were female. Average hemoglobin 
A1C in the control group was 7.93 (SD = 1.49) and 8.03 (SD = 1.95) in the test group (t(56) =  
-0.23, p = 0.82).  
Almost all participants had type 2 diabetes, only two participants had type 1 diabetes in 
the test group. Primary diagnoses were placed into nine categories: musculoskeletal, infection, 
gastrointestinal, cardiac, renal, neurologic, endocrine, pulmonary, and psychiatric. The primary 
diagnoses of the control and test groups did not differ significantly (X2(8, N = 60) = 9.05, p = 
0.34). The most common diagnoses between groups were infection and cardiac related. About 
37% of participants had infection as the primary diagnosis in the control and about 27% in the 
test group. Both groups had 20% of participants with a cardiac-related diagnosis.  
The average LOS was 6.17 days (SD = 5.22) in the control group and 6.21 days (SD = 
4.20) in the test group (t(57) = -0.03, p = 0.97). There was not a significant difference in diet 
between groups (X2(1, N = 60) = 3.27, p = 0.07).  The majority of participants in both groups 
were on diabetic diets, 77% in the control group and 93% in the test group. The majority of 
observed meals were from lunch, 77% in the control groups and 67% in the test group. 
Participants were located in nine different non-critical, acute care units. The majority of 
participants were located on three different units: a cardiopulmonary unit (30%), a medical 
surgical unit (22%), and an orthopedic unit (17%). A complete participant distribution between 
units is found in Appendix D.     
Time Intervals 
 The first aim of the study was to examine if the educational card shortened the time 
intervals between: 
a. CBG and meal tray delivery, 
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b. the administration of insulin and meal tray delivery, 
c. and CBG and the administration of insulin. 
The first aim of the study was not met. There was actually an increase in the time intervals (in 
minutes) between: 
a. CBG and meal tray delivery before (M = 35, SD= 46) and after (M = 47, SD = 
68) implementation (t(56) = -0.83,  p= 0.15),  
b. insulin administration and meal tray delivery before (M = 27, SD = 21) and after 
(M = 32, SD = 45) implementation (t(45) = -.47, p = 0.07), 
c. and CBG and insulin administration before (M = 45, SD = 44) and after (M = 65, 
SD = 77) implementation (t(44) = -1.09, p = 0.03).  
Of the three measured intervals, the interval between CBG and insulin administration achieved 
statistical significance, but the time interval increased. Graphic representation of results is found 
in Appendix E.  
The time interval between meal tray delivery to the nurse’s station and to the patient 
room was also analyzed. The educational card did not significantly decrease the mean time 
interval (in minutes) between tray delivery to the nursing station and tray delivery to the patient 
room before (M = 34, SD = 72) and after (M = 11, SD = 12) implementation (t(29) = 1.24, p = 
0.22). 
Incidence of Hypoglycemia  
The second aim of the study was to examine if the incidence of hypoglycemia (CBG of 
less than 70 mg/dL) decreased in the interval after meal tray delivery and before the next meal. 
There were insufficient data to run meaningful statistics to test this aim. The control group had 
one incidence and the test group had three incidences of hypoglycemia.  
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Percent in Blood Glucose Range 
The third aim of the study was to examine if the percentage of patients in range, 
measured by a target CBG range of 70-180 mg/dL increased after the implementation of the 
educational card. In range was calculated using ADA (2019) standards of hypo- and 
hyperglycemia in the inpatient setting. Anything below 70 mg/dL is hypoglycemia and anything 
above 180 mg/dL is hyperglycemia, with any measure between 70-180mg/dL considered in 
range. The post-meal CBG was used to determine in range or out of range. There was not a 
significant increase in patients in range after the implementation of the educational card, (X2(1, N 
= 53) = 1.52, p = 0.22). About 58% of participants were in range in the control group and about 
41% in the test group were in range.  
Glycemic Control  
 Data were collected for glycemic control through chart review, noting the CBG recorded 
before the observed meal (pre-meal CBG) and the next CBG recorded after the observed meal 
(post-meal CBG). The aim was to gauge glycemic control in the non-critical, acute care setting 
and if the educational card effected post-meal glycemic control. There was not a significant 
difference between pre-meal CBG in the control (M = 168, SD = 72) and test (M = 174, SD = 
81) groups (t(57) = -0.28, p = 0.78). There was also not a significant difference between post-
meal CBG in the control (M = 172, SD = 75) and test (M = 177, SD = 91) groups (t(51) =  -0.24, 
p = 0.81). The educational card did not impact post-meal glycemic control in this sample.  
Subgroups 
 Hemoglobin A1C. Hemoglobin A1C was broken into four groups: 1) control group 
participants with A1C < 7; 2) test group participants with an AlC < 7; 3) control group 
participants with A1C >7; and 4) test group participants with an A1C > 7. A1C categories were 
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based on ADA (2019) recommended A1C target of 7 or less. Hemoglobin A1C tests average 
CBG control over a 3-month period. An A1C of < 7 indicates an average CBG < 154 mg/dL and 
an A1C > 7 indicates an average CBG > 154 mg/dL. The goal was to determine if glycemic 
control varied in response to the educational card when compared to well-controlled CBG and 
poorly controlled CBG. Groups 1 and 2 were compared with post-meal CBG using independent 
samples t-tests. The same analysis was conducted for groups 3 and 4. Post-meal CBG did not 
differ significantly between the control group (M = 151.14, SD = 55.87) and the test group (M = 
147.50, SD = 77.65) with an A1C of < 7 (t(11) = .10, p = 0.92). Similarly, post-meal CBG did 
not differ significantly between the control group (M = 179.61, SD = 83.27) and test group (M = 
190.70, SD = 93.61) with an A1C of > 7 (t(36) = -.38, p = 0.70).    
 Diet order. Diet ordered was broken into four groups: 1) control group participants on a 
diabetic diet; 2) test group participants on a diabetic diet; 3) control group participants on a non-
diabetic diet; and 4) test group participants on a non-diabetic diet. The goal was to determine if 
glycemic control varied in response to the educational card when comparing diets. Groups 1 and 
2 were compared with post-meal CBG using independent samples t-tests. The same analysis was 
conducted for groups 3 and 4.  Post-meal CBG did not differ significantly between the control 
group (M = 181.89, SD = 83.24) and test group (M = 180.64, SD = 92.48) on a diabetic diet 
(t(42) = .05, p = 0.96). Similarly, post-meal CBG did not differ significantly between the control 
group (M = 144.14, SD = 35.08) and test group (M = 135.00, SD = 67.88) on a non-diabetic diet 
(t(7) = .28, p = 0.79). 
 Meal observed. Meal observed were placed into four groups: 1) breakfast observed for 
control group; 2) breakfast observed for test group; 3) lunch observed for control group; and 4) 
lunch observed for test group. The goal was to determine if glycemic control and the time 
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intervals varied in response to the educational card when compared to the observed meal. Groups 
1 and 2 were compared with post-meal CBG and time intervals using independent samples t-
tests. The same analysis was conducted for groups 3 and 4. Post-meal CBG did not differ 
significantly between the control group (M = 199.4, SD = 92.85) and test group (M = 128.00, SD 
= 61.43) during breakfast (t(7) = 1.32, p = 0.23). Similarly, post-meal CBG did not differ 
significantly between the control group (M = 165.14, SD = 70.77) and test group (M = 185.83, 
SD = 93.18) during lunch (t(42) = -0.82, p = 0.42). 
 There was not a significant difference in the interval of time (in minutes) during breakfast 
between: 
a. CBG and meal tray delivery between the control (M = 98, SD = 68) and test (M= 
55, SD = 42) groups (t(8) = 1.19, p = 0.27).   
b. the administration of insulin and meal tray delivery between the control (M = 26, 
SD = 21) and test (M = 19, SD = 15) groups (t(6) = 0.53, p = 0.62,  
c. and CBG and the administration of insulin between the control (M = 102*, SD = 
56) and test (M = 73, SD = 65) groups, (t(5) = 0.63, p = 0.56). *Mean CBG was 
calculated manually due to one outlier within the data.   
Similarly, there was not a significant difference in the interval of time (in minutes) during 
lunch between:  
a. CBG and meal tray delivery between the control (M = 22, SD = 26) and test (M= 
46, SD = 74) groups (t(46) = -1.51, p = 0.14).   
b. the administration of insulin and meal tray delivery between the control (M = 27, 
SD = 23) and test (M = 34, SD = 49) groups (t(37) = -0.58, p = 0.57,  
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c. and CBG and the administration of insulin between the control (M = 32, SD = 30) 
and test (M = 64, SD = 80) groups, (t(37) = -1.61, p = 0.12).  
Discussion 
 This study examined the effectiveness of an educational card on reducing the time 
intervals between CBG and meal tray delivery, the administration of insulin and meal tray 
delivery, and CBG and the administration of insulin. Impact on glycemic control was also 
analyzed. When comparing the control to the test group, the educational card was ineffective at 
reducing the time intervals and did not have a significant impact on glycemic control. The time 
intervals in this sample actually increased with the implementation of the educational card which 
was unexpected and inconsistent with similar studies. 
Time Intervals 
According to current recommendations by ADA (2019), CBG monitoring should occur 
closely before the administration of insulin (a time interval was not specified), and rapid-acting 
insulin, Novolog or Humalog, should be administered 15 minutes before or directly after meal 
consumption. In this study, CBG monitoring did not occur according to current guidelines. On 
average, CBG monitoring occurred 45 minutes before or after insulin administration in the 
control group and 77 minutes before or after insulin administration in the test group. This is 
alarming because if insulin dosage is based on CBG values that are not current, it could lead to 
dosing errors and uncontrolled CBG.   
Similarly, rapid-acting insulin administration did not occur within current guidelines. On 
average insulin administration occurred 27 minutes before or after meal tray delivery in the 
control group and 32 minutes before or after meal tray delivery in the test group. Insulin that is 
not administered on-time severely increases patients’ risk for hyperglycemia. Patient safety is at 
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risk because of the lack of coordination of CBG monitoring, insulin administration, and meal 
tray delivery.   
The educational card did not decrease the time intervals. All time intervals increased in 
the test group compared to the control group, but the only interval that increased significantly 
was the time interval between CBG and insulin administration. Although it is unclear why the 
increase in time between CBG and insulin administration for the test group was statistically 
significant, study limitations likely contributed (see Limitations section). The educational card 
was created based on current recommendations from ADA (2019) and the APRN diabetes 
specialist. Yamamoto et al. (2010) had success improving the coordination of CBG monitoring 
and insulin administration through meal tray markings and identification so it is unlikely the 
educational card was the cause of the increase in the time intervals. More research is needed on 
the intervention or different ways to improve the coordination of CBG and insulin 
administration.   
The educational card did improve the timing between tray delivery to the nursing station 
and to the patient room by 23 minutes in the test group. This finding was not significant and 
could be attributed to the Hawthorne effect. Because the nurses and CNAs knew they were being 
observed by the researcher and APRN, it could have prompted them to deliver the meal tray into 
the patient room quicker.  
Percent in Blood Glucose Range 
The educational card did not significantly impact the percent of participants in range 
(CBG 70-180 mg/dL), although the percentage of participants in range actually decreased by 
17% with the implementation of the educational card in the test group. Again, this can be 
attributed to study limitations (see Limitations section) and confounding factors that impact 
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glycemic control. For example, glycemic control is impacted by patient acuity, stress, insulin 
dosage, and other factors; none of these variables were included in the analysis. 
About 41-58% of total study participants were in range during the study. Since there were 
so few incidences of hypoglycemia, most of those participants experienced hyperglycemia, or a 
CBG of > 180 md/dL. This is consistent with other studies that examine glycemic control in the 
acute care setting; about 38-46% of patients with diabetes experience hyperglycemia (Mendez & 
Umpierrez, 2014). There is a need to re-examine diabetes management in the inpatient setting 
and research interventions to improve glycemic control. 
Glycemic Control  
 The mean pre-meal and post-meal CBGs of both groups fell within the recommended 
non-critical, acute care setting recommendations of 140 – 180 mg/dL. However, standard 
deviations of 72 mg/dL, 81 mg/dL, 75 mg/dL, and 91 md/dL indicate large variations among 
patients and inadequate glycemic control. The educational card did not significantly impact 
glycemic control or the large fluctuations of CBGs between groups.  
 Although the educational card was ineffective at improving glycemic control, this study 
highlights concerning results. In this sample, glycemic control was inadequate which has several 
negative implications. Patient health and safety is at risk. Patient’s with uncontrolled CBG 
during hospitalization are at greater risk for poor clinical outcomes such as infection and death 
(Baker et al., 2006). Uncontrolled CBG also results in longer hospital stays which costs the 
patient and hospitals money. One hospital saved more than $3000 per patient with improved 
glycemic control (Cardona et al., 2017). healthcare staff have a responsibility to model proper 
diabetes management in order to promote optimal diabetes management upon discharge.   
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Subgroups 
 Hemoglobin A1C. The educational card did not impact glycemic control in participants 
with an A1C < 7 and > 7. An A1C of < 7 indicates an average CBG < 154 mg/dL and an A1C > 
7 indicates an average CBG > 154 mg/dL (ADA, 2019). This is consistent with findings as 
participants with an A1C < 7 had mean CBGs of 147 – 151 mg/dL and participants with an A1C 
> 7 had mean CBGs of 180 – 191 mg/dL.  
Participants with an A1C < 7 have optimal glycemic management which indicates proper 
diabetes management in the outpatient setting. Often, patients are not allowed to manage their 
diabetes in the hospital, despite having optimal control in the outpatient setting. These patients 
could benefit from more autonomy and self-diabetes management within the hospitalized setting. 
This reduces the workload of the healthcare staff, results in better glycemic management, and 
improves meal-time insulin coordination (Mabrey & Setji, 2015). Diabetes self-management 
increases autonomy and satisfaction. For patients without optimal diabetes management, or with 
an A1C >7, patient education is essential at promoting healthy habits, increasing health 
awareness, and autonomy (Cobaugh et al., 2013; Engle et al., 2016; Kaisen et al., 2018).  
Diet Ordered. Similarly, the educational card did not impact glycemic control in 
participants on a diabetic or non-diabetic diet. Surprisingly, participants on a non-diabetic diet 
had better CBG control then those on a diabetic diet. CBG ranged from 135 – 144 mg/dL in the 
non-diabetic diet participants and 181 – 182 mg/dL in the diabetic group participants. This is 
unexpected because the purpose of a diabetic diet is to prevent spikes in CBG and improve 
glycemic control through limiting refined sugar intake, foods high in salt, and fried foods 
(National Institute of Diabetes and Digestive and Kidney Diseases, 2016). Of course, the 
fluctuations in CBG could be caused by other factors outside the researcher’s control. For 
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example, without direct observation the exact contents of the meal were not examined and it was 
unknown if the participant had a snack before the post-meal CBG was checked. More research is 
warranted on the effect of diet in the non-critical, acute care setting.  
Meal Observed. When considered separately, the educational card did not significantly 
impact glycemic control during breakfast or lunch. The mean CBG decreased by 71 mg/dL from 
the control to the test groups during breakfast, but the number of participants in that group were 
small so the findings were insignificant. A larger sample size may produce significant results. 
The mean CBG was consistent between breakfast and lunch.  
The educational card did not significantly impact the time intervals during breakfast or 
lunch. All time intervals decreased in the test group during breakfast, but still did not meet 
standards and was insignificant due to small group sample sizes. A larger sample size may 
produce significant results. Overall, timing was slightly better for the control and test groups 
during lunch, which can be attributed to issues at breakfast such as shift change and increased 
patient needs (e.g., medication orders). Few studies compare diabetes management between 
meals in hospitals patients. Future research is needed on the impact of meal time on glycemic 
control. Breakfast and dinner are busy times for the healthcare staff due to patient needs and 
administration responsibilities (e.g., charting, shift change). Future studies should examine nurse 
workload throughout the day and the impact on diabetes management.  
Limitations   
When comparing the control and test groups, the educational card was ineffective at 
improving the time intervals and glycemic control in this sample. Insignificant results are 
attributed to study design and confounding variables outside the researcher’s control. The 
researcher utilized a quasi-experimental, non-equivalent control group before-after design in this 
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study. The non-equivalent control group design may have introduced differences in staffing, unit 
census, and patient acuity. This can impact nursing care and thus, diabetes management. This 
study was strictly observational and did not have an experimental design. Meal tray delivery into 
the patient room was used as a substitute for meal consumption, so the researcher could not 
record when the patient actually consumed the meal. It is possible that the patient could have 
started eating long after meal tray delivery. The nutritional content, such as carbohydrate or 
sugar content, of meals was not accounted for nor were snacks between meals. It was also 
unknown whether or not the patient noticed the educational card on the tray and called the nurse.  
Demographic characteristics were similar between groups, but factors that impact 
workflow were not accounted for, such as hospital or unit census, and staffing patterns. The lack 
of intervention randomization may result in unaccounted differences between groups. Sample 
sizes were also small due to research and APRN time constraints. It is possible that significant 
results would occur with larger sample sizes.  
It is also unknown if the educational card effectively prompted the patient to call the 
nurse and receive insulin before eating. The patient did not receive formal education on the 
educational card so it is unknown if the patient understood the educational card or the 
importance of waiting to eat until insulin is received. The educational card stated, “call your 
nurse for your insulin shot BEFORE you start eating,” which could have prompted the patient to 
call the nurse first and then start eating; instead of calling the nurse, receiving insulin, and then 
eating. Rewording of the educational card may be necessary and could include language such as, 
“call your nurse and wait for your insulin shot BEFORE you start eating.” It is important to 
educate patients on the intervention to promote compliance upon discharge and improve 
glycemic control (Cobaugh et al., 2013; Engle et al., 2016; Kaisen et al., 2018). 
CBG MONITORING AND INSULIN ADMINISTRATION 20 
The healthcare staff, which include nurses and CNAs, had mixed compliance to the 
educational card. Some employees verbalized approval of the intervention while others 
expressed feelings of annoyance and displeasure. Some nurses and CNAs removed the 
educational card before the tray was delivered. Since those patients did not see the card, they 
were removed from the study. It is also possible that the healthcare staff removed the card while 
in the patient room. This reduces intervention fidelity and impacts the data from the test group, 
which makes insignificant results more likely. The healthcare staff was notified of the 
intervention via email and many employees reported that they were not aware of the intervention 
which created confusion on the purpose of the card. Per hospital request, the healthcare staff did 
not receive formal education or module instructions on the use or importance of the educational 
card. Formal and trackable education could have enhanced compliance.   
Proper diabetes management is important to reduce complications. Diabetes is associated 
with long-term complications such as retinopathy, kidney disease, heart disease, strokes, and 
neuropathy (Corsino, Dhatariya, & Umpierrez, 2017). Uncontrolled diabetes also increases risk 
of mortality and decreases life expectancy up to 15 years (Mannucci, Dicembrini, Lauria, & 
Pozzilli, 2013). Improved glycemic management can reduce the risk of complications and 
mortality by 16 – 57% (Holman, Paul, Bethel, Matthews, & Neil, 2008; Mannucci et al., 2013; 
Nathan et al., 2005).  
There are many studies that examine glycemic management in the hospital setting, but 
few that address the specific time intervals between CBG monitoring, meal consumption, and 
insulin administration. Research is limited on interventions to improve diabetes management in 
the hospital setting. Each healthcare system is unique and faces different problems. It is 
important for healthcare systems to examine diabetes management in their own facilities and 
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tailor interventions to best meet the needs of the healthcare staff and patients. To the researcher’s 
knowledge, this study is the first to examine the effectiveness of a patient educational card on 
timing and glycemic control. 
The implications of this study inform hospitals of the need to create better education or 
policies to improve glycemic management. Diabetes management is inadequate in the hospital 
setting and interventions must be developed to address the problem. Even though the education 
was ineffective, it can be modified to fit each hospital’s needs. It is also important to promote 
communication between nurses, CNAs, dietary staff, and the patient to promote optimal diabetes 
management and glycemic control.  
Future Research 
 The educational card may still be a useful tool within hospitals, but further research is 
needed and should include: standardized and trackable staff and patient education, 
interdisciplinary coordination between nurses, CNAs, and dietary staff, larger sample sizes, true 
experimental design, and direct patient contact. The placement of the educational card was the 
sole responsibility of the researcher and APRN, and was not feasible for all patients if meals 
were ordered at the same time and on different units. Healthcare facilities face unique challenges 
on who will place the educational card. Some facilities were successful at dietary staff placing 
markings on patient meal trays that alerted the healthcare staff of patients on insulin, but that 
increases the workload of dietary staff and may disclose confidential patient information 
(Yamamoto et al., 2010). 
It would be useful if the patient was educated on the importance of receiving insulin 
before eating at some point during hospitalization, ideally during admission. An educational card 
can then be placed in patient rooms to serve as a daily reminder of the education. This removes 
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the barrier of placement of the educational card and makes the card more noticeable as opposed 
to on patient meal trays which can be easily missed and removed.   
 While CBG measurement and automated documentation in electronic medical records are 
reliable and valid tools, there were limitations with the measurement of time intervals within this 
study. Interrater reliability must be addressed in future studies to address if data collection 
occurred consistently between data collectors. Furthermore, meal tray delivery is not a valid way 
to measure meal consumption. Direct patient contact to observe the exact timing and duration of 
meal consumption, the contents of the meal, and if insulin was administered before or after meal 
consumption would enhance both reliability and validity of data collection. There is also a need 
to identify if patients saw the educational card, if they understood it, and if they called the nurse 
before meal consumption; understanding intervention fidelity in the test group would improve 
interpretation of statistical conclusion validity. 
 Time-in-range (TIR) can also be analyzed in the future. TIR is the percentage a patient 
spends in-range, with a CBG of 70 – 180 mg/dL. At the beginning of hospitalization for non-
critical patients on rapid-acting insulin, patients can be randomly assigned to control or test 
groups. The test groups have the educational card for their entire hospitalization and CBG is 
examined for their entire stay. TIR is then compared between the control and test groups. This 
way allows the patient to receive formal education on the educational card and allows them to 
see it more than once, which may increase retention and compliance.  
TIR is important to consider when implementing any intervention aimed at improving 
glycemic management because it provides a more wholistic view than mean glucose. Mean 
glucose only collects data from one point in a patient’s hospitalization, which makes it difficult 
to analyze improvements or fluctuations in blood glucose. Improvements in mean glucose could 
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also be attributed to outliers, such as extreme incidences of hypoglycemia. Ideally, TIR would be 
measured with use of continuous CBG monitoring, which is currently not used routinely in 
inpatient settings. 
Conclusion 
 Following implementation of an educational card, there was no reduction in the time 
intervals between CBG monitoring, insulin administration, and meal tray delivery. Timing still 
does not meet current standards which impacts glycemic control. More research is needed to 
address the needs of hospitalized patients with diabetes. The study had a small sample size and 
cannot be generalized to all patients due to confounding influences and the many other factors 
(e.g., patient acuity, unit census) that impact glycemic control and diabetes management. 
Hospitals can use the results of this study to utilize the educational card in a different manner or 
tailor other interventions to meet the needs of patients with diabetes.    
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Appendix A 
Table 1: Literature Review Studies   
Author Study  Aim Findings Limitations 
Yamamoto et al., 
2010 
Experimental Improve timing 
of inpatient 
insulin 
administration 
related to meal 
delivery and 
procedure 
scheduling 
 
The timing of 
inpatient 
insulin 
administration 
related to meal 
delivery and 
testing 
improved 
Additional 
protocol may 
have contributed 
to improved 
glycemic control, 
paired data not 
available for 
every patient 
Engle et al., 
2016 
Quality 
Improvement 
 
Modify the meal 
delivery process 
to improve the 
timing between 
blood glucose 
monitoring and 
insulin 
administration 
and improve 
glycemic control  
 
Blood glucose 
control and the 
timing between 
blood glucose 
monitoring and 
insulin 
administration 
improved after 
the change 
Additional 
protocol may 
have contributed 
to improved 
glycemic control 
Kaisen et al., 
2018 
Descriptive-
correlational 
study  
Identify factors 
that lead to 
timely blood 
glucose 
monitoring and 
insulin 
administration  
Communication 
with CNAs, 
fewer patients, 
and patients 
waiting for 
insulin prior to 
eating were key 
factors and 
receiving 
insulin on time 
 
Response bias, 
social 
desirability, 
Hawthorne 
effect, limited 
generalizability  
Cobaugh et al., 
2013 
Expert 
consensus panel 
Provide 
recommendations 
for safe insulin 
administration 
Development 
of insulin 
protocol, 
hospitals must 
coordinate 
insulin delivery 
better, and 
standardize 
education  
 
Limited 
knowledge of 
application 
within practice 
CBG MONITORING AND INSULIN ADMINISTRATION 28 
Appendix B 
Patient Education Card 
 
 
 
 
 
 
 
 
 
 
 
 
Call your nurse for your insulin shot BEFORE you start eating  
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Appendix C 
Table 2: Demographic Characteristics  
 
 
 
Characteristic   Control Group Test Group  p-value 
Mean age  67 ± 14 
N= 30 
  
65 ± 12 
N= 30 
p = 0.56 
Gender 
 
 
Male: 43%  
Female: 57% 
N= 30 
Male: 37%  
Female: 63% 
N= 30 
 
p = 0.48 
Mean Hemoglobin A1C 
 
7.93 ± 1.49 
N= 29 
 
8.03 ± 1.95 
N= 29 
p = 0.82 
Diabetes Type 
 
 
Type 2: 100% 
Type 1: 0% 
N= 30 
 
Type 2: 93% 
Type 1: 7% 
N= 30 
-- 
Primary Diagnosis 
 
Musculoskeletal: 5  
Infection: 11 
GI: 6 
Cardiac: 1 
Renal: 1 
Neuro: 1 
Endocrine: 1 
Pulmonary: 1 
Psych: 0 
N= 30 
Musculoskeletal: 4 
Infection: 8 
GI: 1 
Cardiac: 6 
Renal: 0 
Neuro: 1 
Endocrine: 3 
Pulmonary: 5 
Psych: 2 
N= 30 
 
p = 0.34 
Mean Length of Stay  6 ± 5 
N= 30  
6 ± 4 
N= 29  
p = 0.97 
Diet Order 
 
 
Diabetic: 77% 
Nondiabetic: 23% 
N= 30 
Diabetic: 93% 
Nondiabetic: 7% 
N= 30 
 
p = 0.07 
Meal Observed 
  
Breakfast: 23%  
Lunch: 77% 
N= 30  
Breakfast: 37%  
Lunch: 67% 
N= 30 
p = 1.0 
No statistically significant differences between groups (all p-values> 
0.05). 
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Appendix D  
Table 3: Participant Unit Distribution  
Unit Unit Type Control Group  
N= 30  
 
Test Group  
N= 30  
Unit 1 Orthopedic 17% 17% 
Unit 2 Medical Surgical 17% 7% 
Unit 3 Medical Surgical 27% 17% 
Unit 4 Cardiac Medical 
Surgical 
13% 3% 
Unit 5 Cardiopulmonary 27% 33% 
Unit 6  Surgical Trauma 0% 3% 
Unit 7 Advanced Care 0% 10% 
Unit 8  Medical Surgical 0% 7% 
Unit 9 Medical Surgical  0% 3% 
No statistically significant differences between groups, p > 0.05. 
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Appendix E 
Table 4: Time Intervals between Control and Test Groups 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*p = 0.03 
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Appendix F 
Table 5: Time Intervals (in minutes) 
Group Statistics 
 IV N Mean Std. Deviation Std. Error Mean 
Time between CBG and Tray 
Delivery  
Control Group 29 35:18 46:03 08:33 
Test Group 29 48:08 69:35 12:55 
Time between Insulin 
Administration and Tray 
Delivery 
Control Group 22 27:08 21:50 04:39 
Test Group 25 32:12 45:50 09:10 
Time between Insulin 
Administration and CBG  
Control Group 22 45:00 44:55 09:34 
Test Group 24 65:40 77:37 15:50 
Time between Tray to Nurse’s 
Station and Tray to Room  
Control Group 15 34:28 72:04 18:36 
Test Group 16 11:45 12:06 03:01 
Note. Paired data were not always available in the control and test groups due to patient discharges, procedures, and lack of 
insulin administration, resulting in variability in N. 
 
 
 
 
 
 
Levene's Test for Equality of 
Variances 
F Sig. t df Sig. (2-tailed) 
Time between CBG and Tray Delivery  Equal variances assumed 2.156 .148 -.828 56 .411 
Equal variances not 
assumed 
  
-.828 48.583 .412 
Time between Insulin Administration and 
Tray Delivery 
Equal variances assumed 3.368 .073 -.473 45 .639 
Equal variances not 
assumed 
  
-.492 35.291 .625 
Time between Insulin Administration and 
CBG  
Equal variances assumed 4.790 .034 -1.092 44 .281 
Equal variances not 
assumed 
  
-1.116 37.405 .271 
Time between Tray to Nurse’s Station and 
Tray to Room  
Equal variances assumed 4.551 .041 1.244 29 .224 
Equal variances not 
assumed 
  
1.205 14.742 .247 
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Table 6: Percent in Blood Glucose Range  
IV * In Range Crosstabulation 
Count   
 
Range (70-180 mg/dL) 
Total In Range Out Range 
IV Control Group 15 11 26 
Test Group 11 16 27 
Total 26 27 53 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 1.523a 1 .217   
Continuity Correctionb .920 1 .337   
Likelihood Ratio 1.530 1 .216   
Fisher's Exact Test    .276 .169 
Linear-by-Linear Association 1.494 1 .222   
N of Valid Cases 53     
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 12.75. 
b. Computed only for a 2x2 table 
 
 
 
 
 
 
 
 
 
CBG MONITORING AND INSULIN ADMINISTRATION 34 
Table 7: Glycemic Control 
Group Statistics 
 
IV N Mean Std. Deviation Std. Error Mean 
Pre-meal CBG Control Group 29 168.2069 71.78111 13.32942 
Test Group 30 173.8667 81.34504 14.85151 
Post-meal CBG Control Group 26 171.7308 74.66863 14.64372 
Test Group 27 177.2593 90.66362 17.44822 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Levene's Test for Equality of Variances 
F Sig. t df Sig. (2-tailed) 
Pre- meal 
CBG 
Equal variances assumed .567 .454 -.283 57 .778 
Equal variances not assumed   -.284 56.540 .778 
Post-meal 
CBG 
Equal variances assumed .645 .426 -.242 51 .810 
Equal variances not assumed   -.243 49.820 .809 
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Table 8: Hemoglobin A1C Subgroup  
Group Statistics 
 IV N Mean Std. Deviation Std. Error Mean 
A1C≤7 + Post-meal CBG Control Group 7 151.1429 55.86719 21.11581 
Test Group 6 147.5000 77.64728 31.69937 
A1C>7 + Post-meal CBG Control Group 18 179.6111 83.26721 19.62627 
Test Group 20 190.7000 93.61123 20.93211 
 
 
 
 
 
 
 
 
 
 
 
Levene's Test for Equality 
of Variances 
F Sig. t df 
Sig. (2-
tailed) 
A1C≤7 + Post-meal CBG Equal variances assumed 1.295 .279 .098 11 .924 
Equal variances not 
assumed 
  
.096 8.953 .926 
A1C>7 + Post-meal CBG Equal variances assumed .002 .962 -.384 36 .703 
Equal variances not 
assumed   
-.386 35.997 .701 
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Table 9: Diet Subgroup  
Group Statistics 
 
IV N Mean Std. Deviation Std. Error Mean 
Diabetic + Post-meal CBG Control Group 19 181.8947 83.23654 19.09577 
Test Group 25 180.6400 92.47787 18.49557 
Non-Diabetic + Post-meal CBG Control Group 7 144.1429 35.08290 13.26009 
Test Group 2 135.0000 67.88225 48.00000 
 
 
 
 
 
 
 
 
 
 
 
Levene's Test for Equality 
of Variances 
F Sig. t df 
Sig. (2-
tailed) 
Diabetic + Post-meal CBG Equal variances 
assumed 
.070 .793 .047 42 .963 
Equal variances not 
assumed 
  
.047 40.730 .963 
Non-Diabetic + Post-meal CBG Equal variances 
assumed 
1.949 .205 .275 7 .791 
Equal variances not 
assumed 
  
.184 1.157 .881 
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Table 10: Meal Observed Subgroup 
Group Statistics 
 IV N Mean Std. Deviation Std. Error Mean 
Breakfast + Post-meal CBG Control Group 5 199.4000 92.84826 41.52301 
Test Group 4 128.0000 61.43289 30.71645 
Lunch + Post-meal CBG Control Group 21 165.1429 70.76813 15.44287 
Test Group 23 185.8261 93.17659 19.42866 
 
 
Levene's Test for Equality 
of Variances 
F Sig. t df 
Sig. (2-
tailed) 
Breakfast + Post-meal CBG Equal variances 
assumed 
.850 .387 1.316 7 .230 
Equal variances not 
assumed 
  
1.382 6.843 .210 
Lunch + Post-meal CBG Equal variances 
assumed 
1.192 .281 -.823 42 .415 
Equal variances not 
assumed 
  
-.833 40.707 .409 
Group Statistics 
 
IV N Mean Std. Deviation Std. Error Mean 
Breakfast +Time between CBG 
and Tray Delivery 
Control Group 5 98:00 68:17 30:32 
Test Group 5 55:24 42:09 18:51 
Lunch + Time between CBG and 
Tray Delivery 
Control Group 24 22:07 26:48 05:28 
Test Group 24 46:37 74:39 15:14 
Breakfast + Time between Tray 
Delivery and Insulin 
Control Group 4 26:30 21:47 10:53 
Test Group 4 19:30 15:09 07:34 
Lunch + Time between Tray 
Delivery and Insulin 
Control Group 18 27:16 22:28 05:17 
Test Group 21 34:37 49:29 10:47 
Breakfast + Time between CBG 
and Insulin 
Control Group 4 ***** 56:52 28:26 
Test Group 3 73:20 65:29 37:48 
Lunch + Time between CBG + 
Insulin 
Control Group 18 32:03 30:32 07:11 
Test Group 21 64:25 80:28 17:33 
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Levene's Test for 
Equality of Variances 
F Sig. t df 
Sig. (2-
tailed) 
Breakfast +Time between CBG and 
Tray Delivery 
Equal variances 
assumed 
1.142 .316 1.187 8 .269 
Equal variances not 
assumed 
  
1.187 6.662 .276 
Lunch + Time between CBG and Tray 
Delivery 
Equal variances 
assumed 
7.546 .009 -1.513 46 .137 
Equal variances not 
assumed 
  
-1.513 28.832 .141 
Breakfast + Time between Tray 
Delivery and Insulin 
Equal variances 
assumed 
.283 .614 .527 6 .617 
Equal variances not 
assumed 
  
.527 5.351 .619 
Lunch + Time between Tray Delivery 
and Insulin 
Equal variances 
assumed 
3.858 .057 -.579 37 .566 
Equal variances not 
assumed 
  
-.610 28.820 .546 
Breakfast + Time between CBG and 
Insulin 
Equal variances 
assumed 
.093 .773 .626 5 .559 
Equal variances not 
assumed 
  
.611 4.041 .574 
Lunch + Time between CBG + Insulin Equal variances 
assumed 
8.064 .007 -1.608 37 .116 
Equal variances not 
assumed 
  
-1.706 26.410 .100 
